People are running their own experiments with GLP-1s — with stunning results

单集文稿 ...

• 00:03

  This is In Conversation from Apple News.

• 00:05

  I'm David Greene, in for Shumita Basu.

• 00:08

  Today, the GLP-1 experiment happening in real time.

• 00:20

  Millions of people in the U.S. are taking GLP-1 medications right now.

• 00:24

  An estimated one in eight adults.

• 00:27

  You probably know these drugs by their brand names, Ozempic, Wegovy, Mounjaro and Zepbound.

• 00:32

  GLP-1-based drugs have been around for years and were originally intended for treating diabetes.

• 00:39

  But they exploded in use when researchers discovered

• 00:43

  they could cause significant weight loss and were approved for treating obesity.

• 00:48

  But people are now reporting improvements

• 00:50

  across a remarkably wide range of other conditions as well,

• 00:53

  from addiction to concussion symptoms to fertility,

• 00:57

  most of which have yet to be formally studied.

• 01:00

  The landscape is changing so fast.

• 01:02

  There's new drugs coming on all the time

• 01:04

  and we're learning in real time what these drugs are doing.

• 01:07

  That is Julia Belluz.

• 01:08

  She's a contributing opinion writer to the New York Times

• 01:11

  and co-author of the book Food Intelligence.

• 01:18

  Julia has been reporting on GLP-1s for years,

• 全部文稿